TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 12nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 16nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 16nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 17nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 17nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 18nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 21nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 24nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 24nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 26nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 29nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 33nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 39nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 39nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 42nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 48nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 51nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetPoly [ADP-ribose] polymerase tankyrase-1 [1068-1325](Homo sapiens (Human))
Institute of Cancer Research
US Patent
Institute of Cancer Research
US Patent
Affinity DataIC50: 76nMAssay Description:Tankyrase activity was assayed using a 96-well format HT Universal Chemiluminescent PARP Assay Kit (Trevigen, Inc, cat. no. 4676-096-K) according to ...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 4(Homo sapiens (Human))
Imperial College Innovations
US Patent
Imperial College Innovations
US Patent
Affinity DataIC50: <100nMAssay Description:Compounds of the present invention were screened for their inhibitory activity against MAP4K4, versus selected off-target hits found with early membe...More data for this Ligand-Target Pair